Thus, the causes of CD295 and ITLN1 genes and their downstream protein products are numerous; therefore, if we detect genetic mutations/polymorphisms in these genes in BC cases with or without obesity, IR, or diabetes, this would direct the treatment plan for a better prognosis. Here, ITLN1 is linked to breast cancer.